SWEDISH ORPHAN BIOVITRUM

• 21200 - Manufacture of pharmaceutical preparations

Sobi is a specialised international biopharmaceutical company transforming the lives of people with rare and debilitating diseases... At Sobi North America, we are inspired by a single vision - to be recognized as a global leader in providing innovative medicines that transform the lives of people with rare and debilitating diseases... Sobi is dedicated to developing and delivering innovative therapies to improve the lives of rare disease patients.

Also known as: Sobi, Sobi North America, Swedish Orphan Biovitrum (Belgium) BV, Swedish Orphan Biovitrum (The Netherlands) B.V., Swedish Orphan Biovitrum AB, Swedish Orphan Biovitrum AB (publ), Swedish Orphan Biovitrum AG, Swedish Orphan Biovitrum AS, Swedish Orphan Biovitrum GmbH, SWEDISH ORPHAN BIOVITRUM LTD, Swedish Orphan Biovitrum Pty Ltd, Swedish Orphan Biovitrum S.R.L., Swedish Orphan Biovitrum SARL, Swedish Orphan Biovitrum, S.L., Swedish Orphan Biovitrum, s.r.o.

Previous names: SWEDISH ORPHAN INTERNATIONAL LTD

Registration numbers: 04369760 (CH), 556038-9321 (W)

Primary location: Basel Switzerland